Similar articles

• Effect of infliximab on refractory uveitis in Behcet's disease.

  Sayarlioglu M, Cinal A, Topcu N, Demirok A. Sayarlioglu M, et al. Ann Pharmacother. 2004 May;38(5):901-2. doi: 10.1345/aph.1D361. Epub 2004 Mar 9. Ann Pharmacother. 2004. PMID: 15010522 No abstract available.
• Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.

  Kotter I, Deuter C, Stubiger N, Zierhut M. Kotter I, et al. J Rheumatol. 2005 Aug;32(8):1633; author reply 1634. J Rheumatol. 2005. PMID: 16078350 No abstract available.
• Efficacy of infliximab on the acute attack of uveitis.

  Alokaily F, Alsaleh S, Al-Balawi M, Al-Rashidi S. Alokaily F, et al. Saudi Med J. 2010 Jan;31(1):82-5. Saudi Med J. 2010. PMID: 20062906
• Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

  Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H. Sfikakis PP, et al. Rheumatology (Oxford). 2007 May;46(5):736-41. doi: 10.1093/rheumatology/kem034. Epub 2007 Apr 2. Rheumatology (Oxford). 2007. PMID: 17403712 Review. No abstract available.
• Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.

  Pipitone N, Olivieri I, Padula A, D'angelo S, Nigro A, Zuccoli G, Boiardi L, Salvarani C. Pipitone N, et al. Arthritis Rheum. 2008 Feb 15;59(2):285-90. doi: 10.1002/art.23345. Arthritis Rheum. 2008. PMID: 18240181 Review. No abstract available.